Last reviewed · How we verify
Placebo oxycodone/acetaminophen tablets — Competitive Intelligence Brief
Target snapshot
Placebo oxycodone/acetaminophen tablets (Placebo oxycodone/acetaminophen tablets) — Purdue Pharma LP. This is a placebo formulation containing no active pharmaceutical ingredients, used as a control in clinical trials to establish the true efficacy of oxycodone/acetaminophen combination therapy.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo oxycodone/acetaminophen tablets TARGET | Placebo oxycodone/acetaminophen tablets | Purdue Pharma LP | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo oxycodone/acetaminophen tablets CI watch — RSS
- Placebo oxycodone/acetaminophen tablets CI watch — Atom
- Placebo oxycodone/acetaminophen tablets CI watch — JSON
- Placebo oxycodone/acetaminophen tablets alone — RSS
Cite this brief
Drug Landscape (2026). Placebo oxycodone/acetaminophen tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-oxycodone-acetaminophen-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing